IsoPlexis Competitors and Similar CompaniesClear all
IsoPlexis's competitors and similar companies include Biocartis.
 IsoPlexis IsoPlexis is a company that develops a diagnostic platform for immunology research and therapeutic development. |  Biocartis Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. | |
Founding Date | Founding Date 2013 | Founding Date 2007 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Branford, US HQ Shanghai, CN Birmingham, GB | Locations Jersey City, US HQ Meadowbrook, AU Mechelen, BE Sofia, BG Huechuraba, CL Zagreb, HR Espoo, FI see more |
Employees | Employees 29037% decrease | Employees 52614% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $16.8m (FY, 2022) | Revenue (est.) €47.4m (FY, 2023) |
Cost of goods | Cost of goods $17.7m (FY, 2022) | Cost of goods €12.4m (FY, 2023) |
Gross profit | Gross profit ($925k) (FY, 2022) | Gross profit €35.3m (FY, 2023) |
Net income | Net income ($106m) (FY, 2022) | Net income €18.4m (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 171.8m | Total funding raised $ 321.2m |
For sources of this data, please see the company profile
View Company Profiles
Biocartis
HQ
Jersey City, US
Employees
526↑ 14% increase
Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry.
View company